Cipla Limited has informed the Exchange regarding a press release dated April 28, 2021, titled "Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment".
Press Release Apr 28 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Cipla
- Press Release Mar 23 2021
- Press Release Mar 18 2021
- Press Release Mar 02 2021
- Press Release Jan 29 2021
- Press Release Jan 27 2021
Later from Cipla
- Press Release May 05 2021
- Press Release May 10 2021
- Press Release May 14 2021
- Press Release May 20 2021
- Press Release May 24 2021
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla